196 related articles for article (PubMed ID: 10515037)
1. [Choice of anti-helicobacter treatment of gastroduodenal ulcer associated with helicobater pylori].
Starostin BD
Ter Arkh; 1999; 71(8):46-50. PubMed ID: 10515037
[TBL] [Abstract][Full Text] [Related]
2. [Results of an open multicenter study of the efficiency of one-week anti-helicobacter therapy using omeprazole, clarithromycin, and amoxicillin in patients with duodenal peptic ulcer].
Isakov VA; Maev IV; Simanenkov VI; Kononov AV; Abdulkhakov RA; Zakharova NV; Livzan MA; Predvechnaia IK
Ter Arkh; 2003; 75(11):71-3. PubMed ID: 14708448
[TBL] [Abstract][Full Text] [Related]
3. Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori?
Güliter S; Keleş H; Ozkurt ZN; Cengiz DU; Kolukisa E
Turk J Gastroenterol; 2005 Mar; 16(1):29-33. PubMed ID: 16252185
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of Helicobacter pylori infection in patients with duodenal ulcer: a cost-benefit study].
Rollán A; Giancaspero R; Acevedo C; Fuster F; Hola K
Rev Med Chil; 2000 Apr; 128(4):367-77. PubMed ID: 10962853
[TBL] [Abstract][Full Text] [Related]
5. [Modern policy of anti-helicobacter therapy of ulcer disease].
Ryss ES
Klin Med (Mosk); 1998; 76(10):7-11. PubMed ID: 9865008
[No Abstract] [Full Text] [Related]
6. [Quamatel application in three-drug eradication therapy of duodenal ulcer and gastroduodenal ulcerations associated with helicobacter pylori infection].
Mansurova FKh; Kadyrov DM; Odinaev RI; Ishankulova DM
Klin Med (Mosk); 2000; 78(6):53-6. PubMed ID: 10900873
[TBL] [Abstract][Full Text] [Related]
7. [Clinical efficacy of combined anti-Helicobacter treatment of patients with duodenal ulcer].
Kirika NV; Bodrug NI; Butorov SI; Verbitskiĭ ON; Ridlovskiĭ AIu; Butorov IV; Lagutkin DI; Martyniuk LI
Klin Med (Mosk); 2003; 81(1):37-9. PubMed ID: 12650094
[TBL] [Abstract][Full Text] [Related]
8. [Level of Helicobacter pylori infection of the gastric mucosa in the optimization of a daily dose of antihelicobacter drugs].
Orziev ZM; Nurbaev FE; Rakhimova GSh
Klin Med (Mosk); 2003; 81(10):34-6. PubMed ID: 14664171
[TBL] [Abstract][Full Text] [Related]
9. [Cost-effectiveness analysis of the eradication of Helicobacter pylori as treatment for duodenal ulcer].
Fernández Muñoz J; López de Andrés A; Zapater Hernández P; Abad Santos F
An Med Interna; 1998 Oct; 15(10):515-22. PubMed ID: 9844225
[TBL] [Abstract][Full Text] [Related]
10. [Prognostic factors of efficacy of eradication therapy in patients with duodenal ulcer].
Kozlova IV; Eliseev IuIu; Pakhomova AL; Khan SA
Klin Med (Mosk); 2005; 83(7):52-5. PubMed ID: 16117427
[TBL] [Abstract][Full Text] [Related]
11. Eradication of Helicobacter pylori does not reduce the incidence of gastroduodenal ulcers in patients on long-term NSAID treatment: double-blind, randomized, placebo-controlled trial.
de Leest HT; Steen KS; Lems WF; Bijlsma JW; van de Laar MA; Huisman AM; Vonkeman HE; Houben HH; Kadir SW; Kostense PJ; van Tulder MW; Kuipers EJ; Boers M; Dijkmans BA
Helicobacter; 2007 Oct; 12(5):477-85. PubMed ID: 17760715
[TBL] [Abstract][Full Text] [Related]
12. [Lansoprazole versus ranitidine bismuth citrate containing triple regimens for Helicobacter pylori eradication in patients with duodenal ulcer].
Buzás György M; Székely E; Illyés G; Széles I
Orv Hetil; 2000 Jul; 141(31):1711-4. PubMed ID: 10976194
[TBL] [Abstract][Full Text] [Related]
13. [Effects of mono- and combined peptic ulcer therapy on lipid peroxidation and antioxidant defense in ulcerous zone].
Esedov EM; Mamaev SN
Klin Med (Mosk); 1998; 76(1):28-31. PubMed ID: 9532911
[TBL] [Abstract][Full Text] [Related]
14. [Eradication of Helicobacter pylori infection. A new therapy standard for duodenal ulcer].
Caspary WF; Braden B
Internist (Berl); 1996 Dec; 37(12):1204-11. PubMed ID: 9081921
[No Abstract] [Full Text] [Related]
15. [Efficacy of different schemes of anti-helicobacter therapy in duodenal ulcer].
Kirika NV; Bodrug NI; Butorov IV; Butorov SI
Ter Arkh; 2004; 76(2):18-22. PubMed ID: 15106408
[TBL] [Abstract][Full Text] [Related]
16. Helicobacter pylori eradication in duodenal ulcer disease is cost-beneficial: a Belgian model.
Deltenre M; Ilunga KO
J Physiol Pharmacol; 1997 Sep; 48 Suppl 4():107-13. PubMed ID: 9440061
[TBL] [Abstract][Full Text] [Related]
17. [Helicobacter pylori and gastroduodenal pathology. Second part: Clinical aspects and therapy].
Sobhani I; Flourié B; Lavergne A; Colimon R; Mignon M; Modigliani R; Rambaud JC
Gastroenterol Clin Biol; 1991; 15(5):412-20. PubMed ID: 2070962
[No Abstract] [Full Text] [Related]
18. [Medico-economic aspects of the treatment of duodenal ulcer: from antisecretory treatment to eradication of Helicobacter pylori].
Carrère MO; Auquier P; Poynard T; Sambuc R
Gastroenterol Clin Biol; 1995 Dec; 19(12):1023-30. PubMed ID: 8729415
[TBL] [Abstract][Full Text] [Related]
19. [The impact of the degree of Helicobacter pylori semination of the mucous coat of stomach in patients with duodenal ulcer on the infectious organism's eradication].
Kas'ianenko VI
Eksp Klin Gastroenterol; 2004; (3):19-23, 102. PubMed ID: 15560395
[TBL] [Abstract][Full Text] [Related]
20. Pretreatment antimicrobial susceptibility testing is cost saving in the eradication of Helicobacter pylori.
Romano M; Marmo R; Cuomo A; De Simone T; Mucherino C; Iovene MR; Montella F; Tufano MA; Del Vecchio Blanco C; Nardone G
Clin Gastroenterol Hepatol; 2003 Jul; 1(4):273-8. PubMed ID: 15017668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
